Cargando…
PPARγ and MEK Interactions in Cancer
Peroxisome proliferator-activated receptor-gamma (PPARγ) exerts multiple functions in determination of cell fate, tissue metabolism, and host immunity. Two synthetic PPARγ ligands (rosiglitazone and pioglitazone) were approved for the therapy of type-2 diabetes mellitus and are expected to serve as...
Autores principales: | Burgermeister, Elke, Seger, Rony |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440494/ https://www.ncbi.nlm.nih.gov/pubmed/18596912 http://dx.doi.org/10.1155/2008/309469 |
Ejemplares similares
-
Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasis
por: Procaccia, Shiri, et al.
Publicado: (2017) -
Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer
por: Cheng, Hongge, et al.
Publicado: (2013) -
PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008) -
The Role of PPAR-γ and Its Interaction with COX-2 in Pancreatic Cancer
por: Eibl, Guido
Publicado: (2008) -
Mitogen-Activated Protein Kinase and Exploratory Nuclear Receptor Crosstalk in Cancer Immunotherapy
por: Burgermeister, Elke
Publicado: (2023)